Qiagen N.V. (QGEN) DCF Valuation

Qiagen N.V. (Qgen) تقييم DCF

NL | Healthcare | Medical - Diagnostics & Research | NYSE
Qiagen N.V. (QGEN) DCF Valuation

Fully Editable: Tailor To Your Needs In Excel Or Sheets

Professional Design: Trusted, Industry-Standard Templates

Investor-Approved Valuation Models

MAC/PC Compatible, Fully Unlocked

No Expertise Is Needed; Easy To Follow

Qiagen N.V. (QGEN) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL: $121 $71

كمستثمر أو محلل ، فإن حاسبة DCF [QGEN] هذه هي موردك للتقييم الدقيق. يضم بيانات حقيقية من Qiagen N.V. ، يمكنك بسهولة ضبط التنبؤات ومراقبة التأثيرات على الفور.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2020		 AY2
2021		 AY3
2022		 AY4
2023		 AY5
2024		 FY1
2025		 FY2
2026		 FY3
2027		 FY4
2028		 FY5
2029
Revenue 1,870.3 2,251.7 2,141.5 1,965.3 1,978.2 2,017.4 2,057.3 2,098.0 2,139.5 2,181.9
Revenue Growth, % 0.00 20.39 -4.89 -8.23 0.66 1.98 1.98 1.98 1.98 1.98
EBITDA 715.8 895.2 779.4 688.6 702.1 746.2 761.0 776.1 791.4 807.1
EBITDA, % 38.27 39.76 36.39 35.04 35.49 36.99 36.99 36.99 36.99 36.99
Depreciation 205.0 214.9 208.4 205.3 203.3 205.6 209.6 213.8 218.0 222.3
Depreciation, % 10.96 9.55 9.73 10.45 10.28 10.19 10.19 10.19 10.19 10.19
EBIT 510.8 680.3 571.0 483.2 498.8 540.7 551.4 562.3 573.4 584.7
EBIT, % 27.31 30.21 26.66 24.59 25.21 26.80 26.80 26.80 26.80 26.80
Total Cash 714.3 1,065.3 1,418.3 1,057.8 1,153.0 0.0 0.0 0.0 0.0 0.0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 439.9 469.7 333.5 515.6 349.3
Account Receivables, % 23.52 20.86 15.57 26.24 17.66
Inventories 291.2 327.5 358.0 398.4 279.3 327.6 334.1 340.7 347.5 354.3
Inventories, % 15.57 14.55 16.72 20.27 14.12 16.24 16.24 16.24 16.24 16.24
Accounts Payable 118.2 101.2 98.7 84.2 83.3 96.4 98.3 100.3 102.3 104.3
Accounts Payable, % 6.32 4.50 4.61 4.28 4.21 4.78 4.78 4.78 4.78 4.78
Capital Expenditure -304.2 -206.5 -149.3 -162.8 -167.2 -198.3 -202.2 -206.2 -210.3 -214.5
Capital Expenditure, % -16.27 -9.17 -6.97 -8.28 -8.45 -9.83 -9.83 -9.83 -9.83 -9.83
Tax Rate, % 52.47 18.09 17.44 20.59 30.99 27.92 27.92 27.92 27.92 27.92
EBITAT 242.8 557.2 471.4 383.7 344.2 389.7 397.4 405.3 413.3 421.5
Depreciation 205.0 214.9 208.4 205.3 203.3 205.6 209.6 213.8 218.0 222.3
Changes in Account Receivables -69.7 -8.3 -8.5 -8.6 -8.8
Changes in Inventories -48.3 -6.5 -6.6 -6.8 -6.8
Changes in Accounts Payable 13.1 1.9 2.0 2.0 2.0
Capital Expenditure -304.2 -206.5 -149.3 -162.8 -167.2 -198.3 -202.2 -206.2 -210.3 -214.5
UFCF -469.3 482.5 633.7 189.1 664.9 292.1 392.0 399.7 407.6 415.7
WACC, % 6.17 6.34 6.35 6.33 6.28 6.30 6.30 6.30 6.30 6.30
PV UFCF 274.8 346.9 332.8 319.3 306.3
SUM PV UFCF 1,580.0
Long Term Growth Rate, % 4.00
Free cash flow (T + 1) 432.3
Terminal Value 18,796.9
Present Terminal Value 13,849.0
Enterprise Value 15,429.0
Net Debt 728.0
Equity Value 14,701.0
Diluted Shares Outstanding, MM 225.0
Equity Value Per Share 65.34

What You Will Get

  • Real QGEN Financials: Access to both historical and projected data for precise valuation.
  • Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
  • Dynamic Calculations: Intrinsic value and NPV are computed automatically.
  • Scenario Analysis: Evaluate various scenarios to assess Qiagen’s future performance.
  • User-Friendly Design: Designed for professionals but easy for beginners to navigate.

Key Features

  • 🔍 Real-Life QGEN Financials: Pre-filled historical and projected data for Qiagen N.V.
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Qiagen’s intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Qiagen’s valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  • Download: Obtain the pre-built Excel file containing Qiagen N.V.'s (QGEN) financial data.
  • Customize: Modify projections, including revenue growth rates, EBITDA %, and WACC.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Generate various forecasts and instantly compare the results.
  • Make Decisions: Leverage the valuation findings to inform your investment approach.

Why Choose the Qiagen N.V. ([QGEN]) Calculator?

  • Accuracy: Utilizes real Qiagen financial data to ensure precise calculations.
  • Flexibility: Built for users to easily experiment with and adjust inputs as needed.
  • Time-Saving: Eliminate the need to construct a DCF model from the ground up.
  • Professional-Grade: Crafted with the expertise and usability expected at the CFO level.
  • User-Friendly: Intuitive enough for anyone, regardless of their financial modeling background.

Who Should Use This Product?

  • Professional Investors: Develop comprehensive and accurate valuation models for analyzing Qiagen N.V. (QGEN) investments.
  • Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
  • Consultants and Advisors: Deliver precise valuation insights for clients interested in Qiagen N.V. (QGEN) stock.
  • Students and Educators: Utilize real-time data to enhance learning and practice in financial modeling.
  • Biotech Enthusiasts: Gain insights into how biotech companies like Qiagen N.V. (QGEN) are assessed in the financial markets.

What the Qiagen Template Contains

  • Preloaded QGEN Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.

No products were found matching.